Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-17-000393
Filing Date
2017-11-09
Accepted
2017-11-09 14:31:27
Documents
25
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin1026form10q.htm 10-Q 124887
2 EXHIBIT 31.1 skin1026form10qexh31_1.htm EX-31.1 8389
3 EXHIBIT 31.2 skin1026form10qexh31_2.htm EX-31.2 8402
4 EXHIBIT 32.1 skin1026form10qexh32_1.htm EX-32.1 4576
  Complete submission text file 0001554795-17-000393.txt   523177

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20170930.xml EX-101.INS 25901
6 XBRL SCHEMA FILE skin-20170930.xsd EX-101.SCH 6917
7 XBRL CALCULATION FILE skin-20170930_cal.xml EX-101.CAL 16442
8 XBRL DEFINITION FILE skin-20170930_def.xml EX-101.DEF 4883
9 XBRL LABEL FILE skin-20170930_lab.xml EX-101.LAB 58030
10 XBRL PRESENTATION FILE skin-20170930_pre.xml EX-101.PRE 39919
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 171190164
SIC: 6770 Blank Checks